Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 50%Moderate 1 · 50%High 0 · 0%

Serious adverse events: death · Dialysis vascular access outcomes in AVF patients with ESKD

Omega‐3 fatty acids showed no clear difference in serious adverse events: death compared with placebo (moderate certainty).

1 finding from 1 review

Serious adverse events: death · dialysis vascular access outcomes in AVG patients with ESKD

Omega‐3 fatty acids showed no clear difference in serious adverse events: death compared with placebo (low certainty).

1 finding from 1 review